Extracorporeal membrane oxygenation rescue for H1N1 acute respiratory distress syndrome: equipoise regained

Research output: Contribution to journalLetterOther

12 Citations (Scopus)

Abstract

In this issue of the Journal, Pham and colleagues (pp. 276?285) report patient outcomes after extracorporeal membrane oxygenation (ECMO) as a rescue therapy for acute respiratory distress syndrome (ARDS) during the 2009?2011 H1N1 influenza pandemic (1). Patients who received ECMO were compared with largely concurrent patients with H1N1 ARDS who did not have ECMO, by matching patient characteristics using propensity scoring. The pandemic timing did not permit a randomized controlled trial, but it provided a unique opportunity to study a substantial sample of patients receiving venovenous ECMO for ARDS in France from a single etiology. The REVA investigators are to be congratulated for building the impressive collaborative national network of clinician-investigators that enabled this research.
Original languageEnglish
Pages (from-to)224 - 226
Number of pages3
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume187
Issue number3
DOIs
Publication statusPublished - 2013

Cite this

@article{fce8781aaa854b228709f183de2fb1be,
title = "Extracorporeal membrane oxygenation rescue for H1N1 acute respiratory distress syndrome: equipoise regained",
abstract = "In this issue of the Journal, Pham and colleagues (pp. 276?285) report patient outcomes after extracorporeal membrane oxygenation (ECMO) as a rescue therapy for acute respiratory distress syndrome (ARDS) during the 2009?2011 H1N1 influenza pandemic (1). Patients who received ECMO were compared with largely concurrent patients with H1N1 ARDS who did not have ECMO, by matching patient characteristics using propensity scoring. The pandemic timing did not permit a randomized controlled trial, but it provided a unique opportunity to study a substantial sample of patients receiving venovenous ECMO for ARDS in France from a single etiology. The REVA investigators are to be congratulated for building the impressive collaborative national network of clinician-investigators that enabled this research.",
author = "Cooper, {David James} and Hodgson, {Carol Lynette}",
year = "2013",
doi = "10.1164/rccm.201211-2052ED",
language = "English",
volume = "187",
pages = "224 -- 226",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "3",

}

TY - JOUR

T1 - Extracorporeal membrane oxygenation rescue for H1N1 acute respiratory distress syndrome: equipoise regained

AU - Cooper, David James

AU - Hodgson, Carol Lynette

PY - 2013

Y1 - 2013

N2 - In this issue of the Journal, Pham and colleagues (pp. 276?285) report patient outcomes after extracorporeal membrane oxygenation (ECMO) as a rescue therapy for acute respiratory distress syndrome (ARDS) during the 2009?2011 H1N1 influenza pandemic (1). Patients who received ECMO were compared with largely concurrent patients with H1N1 ARDS who did not have ECMO, by matching patient characteristics using propensity scoring. The pandemic timing did not permit a randomized controlled trial, but it provided a unique opportunity to study a substantial sample of patients receiving venovenous ECMO for ARDS in France from a single etiology. The REVA investigators are to be congratulated for building the impressive collaborative national network of clinician-investigators that enabled this research.

AB - In this issue of the Journal, Pham and colleagues (pp. 276?285) report patient outcomes after extracorporeal membrane oxygenation (ECMO) as a rescue therapy for acute respiratory distress syndrome (ARDS) during the 2009?2011 H1N1 influenza pandemic (1). Patients who received ECMO were compared with largely concurrent patients with H1N1 ARDS who did not have ECMO, by matching patient characteristics using propensity scoring. The pandemic timing did not permit a randomized controlled trial, but it provided a unique opportunity to study a substantial sample of patients receiving venovenous ECMO for ARDS in France from a single etiology. The REVA investigators are to be congratulated for building the impressive collaborative national network of clinician-investigators that enabled this research.

UR - http://www.atsjournals.org/doi/abs/10.1164/rccm.201211-2052ED?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&

U2 - 10.1164/rccm.201211-2052ED

DO - 10.1164/rccm.201211-2052ED

M3 - Letter

VL - 187

SP - 224

EP - 226

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 3

ER -